-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 L8iioYARN6orNjVNRilLiHvPet1lr15Ax+hXP9vsnfGFWfPPKV4aWYqU+4X0eG9V
 tQOEotFicIbsKdkFK/naTQ==

<SEC-DOCUMENT>0000318306-06-000015.txt : 20061005
<SEC-HEADER>0000318306-06-000015.hdr.sgml : 20061005
<ACCEPTANCE-DATETIME>20060803160138
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000318306-06-000015
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20060803

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACCESS PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000318306
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				830221517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		2600 N STEMMONS FRWY
		STREET 2:		STE 176
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75207
		BUSINESS PHONE:		2149055100

	MAIL ADDRESS:	
		STREET 1:		2600 N STEMMONS FRWY
		STREET 2:		STE 176
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMEX PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMEX CORP/WY
		DATE OF NAME CHANGE:	19831102
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Access Pharmaceuticals, Inc
2600 Stemmons Freeway, Suite 176
Dallas, Texas 75207


August 3, 2006


Office of the Chief Counsel
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, DC  20549
Attn: Ms. Son Brandon

Re: Access Pharmaceuticals, Inc.
    Registration Statement on Form S-1 (File Number 333-135724)

Dear Ms. Brandon:

Access Pharmaceuticals, Inc. hereby requests that its Registration
Statement on Form S-1 (File No. 333-135724) be declared effective
as of the date and time set forth below, or as soon thereafter as is
practicable, unless you are orally notified to the contrary by us prior
to such time:

Requested date of effectiveness: August 7, 2006

Requested time of effectiveness: 9:00 a.m.


Please do not hesitate to call John J. Concannon III, Esq. of Bingham
McCutchen LLP at (617-951-8874) or the undersigned at (214-905-5100)
with any questions or comments you might have.


ACCESS PHARMACEUTICALS, INC>

/s/ Stephen B. Thompson
- -----------------------

Stephen B. Thompson
Vice President,
Chief Financial Officer,
Treasurer

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
